Proteome Sciences plc (PMSNF)

Market Cap	13.86M
Revenue (ttm)	6.12M
Net Income (ttm)	-4.26M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	19,195
Open	0.0449
Previous Close	0.0500
Day's Range	0.0449 - 0.0449
52-Week Range	0.0170 - 0.0785
Beta	-0.01
RSI	50.04
Earnings Date	Aug 4, 2025

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling p...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 36
• Stock Exchange: OTCMKTS
• Ticker Symbol: PMSNF

Financial Performance

In 2024, Proteome Sciences's revenue was 4.89 million, a decrease of -2.80% compared to the previous year's 5.03 million. Losses were -3.41 million, 39.4% more than in 2023.

Financial numbers in GBP